Form 4: BG director receives 6,525 restricted shares on 09/02/2025
Rhea-AI Filing Summary
Bunge Global SA director Eliane Aleixo Lustosa de Andrade acquired 6,525 shares of the issuer's common stock on 09/02/2025. The transaction is reported on a Form 4 filed under Section 16 and shows the shares were received as restricted stock units pursuant to a dividend feature of the company's long-term incentive plans. The record lists a price of $82.44 and indicates the shares are held in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Positive
- Director received equity alignment via 6,525 restricted stock units, aligning management and shareholder interests
- Clear disclosure of transaction date (09/02/2025), amount (6,525 shares), and instrument (restricted stock units) in compliance with Section 16
Negative
- None.
Insights
TL;DR: Routine insider award vesting increases director's stake; no trading disposition or material change to control.
The filing documents a non‑derivative acquisition of 6,525 common shares by a director via restricted stock units that vested under a dividend feature of the long‑term incentive plan. The transaction occurred at an indicated price of $82.44 on September 2, 2025, and is recorded as direct ownership. This appears to be a compensation‑related issuance rather than an open‑market purchase or sale, so it is typically not a liquidity or control event. For valuation or dilution impact, investors should compare the share amount to total outstanding shares (not provided here).
TL;DR: Standard executive compensation vesting; disclosure follows Section 16 reporting conventions.
The report clearly identifies the reporting person as a director and discloses acquisition of shares via plan‑based restricted stock units with a dividend feature. The filing was executed by an attorney‑in‑fact and includes the required Form 4 particulars (transaction date, amount, ownership form). This is a routine governance disclosure of compensation realization and does not indicate departure, related‑party transaction, or change in board composition based on the provided information.